Durvalumab Is Not Superior to Cetuximab in Head, Neck Cancer ...Middle East

Medscape - News
Durvalumab did not improve outcomes compared with cetuximab in patients with head and neck squamous cell carcinoma who are ineligible for cisplatin, new findings indicate. Medscape Medical News

Hence then, the article about durvalumab is not superior to cetuximab in head neck cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Durvalumab Is Not Superior to Cetuximab in Head, Neck Cancer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News